Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$55,754,221
-$106,341,729 QoQ
Shares Held
441,303
-62.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#199
of 2,275 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $440,141,055 across 10 Drug Manufacturers - General names. GILD ranks #4 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
511,025 | $129,785,019 | |
| 2 | LLY |
ELI LILLY & Co
|
93,080 | $111,642,953 | |
| 3 | MRK |
Merck & Co., Inc.
|
547,569 | $70,362,616 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
441,303 | $55,754,221 | |
| 5 | ABBV |
AbbVie Inc.
|
134,479 | $33,840,295 | |
| 6 | AMGN |
Amgen Inc
|
37,717 | $13,658,080 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
173,350 | $9,988,427 | |
| 8 | PFE |
Pfizer Inc
|
375,974 | $9,053,453 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,754,221 | 441,303 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $162,095,950 | 1,163,062 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,169,659 | 74,708 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,258,288 | 83,408 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,247,444 | 83,408 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,446,711 | 84,308 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,390,433 | 69,183 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,861,757 | 69,916 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,851,824 | 70,716 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||